SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-056346
Filing Date
2017-11-06
Accepted
2017-11-06 07:32:04
Documents
9
Period of Report
2017-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv478543_8k.htm 8-K 30238
2 EXHIBIT 1.1 tv478543_ex1-1.htm EX-1.1 157736
3 EXHIBIT 4.1 tv478543_ex4-1.htm EX-4.1 122702
4 EXHIBIT 5.1 tv478543_ex5-1.htm EX-5.1 11095
5 EXHIBIT 10.1 tv478543_ex10-1.htm EX-10.1 215182
6 EXHIBIT 10.2 tv478543_ex10-2.htm EX-10.2 18670
7 EXHIBIT 99.1 tv478543_ex99-1.htm EX-99.1 9716
8 GRAPHIC tv478543_ex99-1logo.jpg GRAPHIC 16308
9 GRAPHIC tv478543ex5-1img01.jpg GRAPHIC 12253
  Complete submission text file 0001144204-17-056346.txt   606311
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 171178243
SIC: 2834 Pharmaceutical Preparations